West Announces Third Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Wells Fargo Upgrades West Pharmaceutical (WST) to Outperform
October 28, 2016 7:11 AM EDTWells Fargo upgraded West Pharmaceutical (NYSE: WST) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on West Pharmaceutical click here. For more ratings news on West Pharmaceutical click here.
Shares of West Pharmaceutical closed at $72.42 yesterday.
... MoreWest Pharma (WST) Reports In-Line Q3 EPS; Narrows EPS Outlook
October 27, 2016 8:16 AM EDTWest Pharma (NYSE: WST) reported Q3 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue for the quarter came in at $376.7 million versus the consensus estimate of $371.25 million.
GUIDANCE:
West Pharma sees FY2016 EPS of $2.17-$2.22, versus prior guidance of... More
